Table 2 DNA (%) presented in “head” and “tail” pre- and post-incubation with melphalan in breast cancer cell lines
Control | Melphalan (1 μM ) | |||
|---|---|---|---|---|
% DNA | % DNA | % DNA | % DNA | |
(mean ± 1.96 S.E.) | (mean ± 1.96 S.E.) | (mean ± 1.96 S.E.) | (mean ± 1.96 S.E.) | |
in Head | in Tail | in Head | in Tail | |
MCF-7 | 66.43 ± 3.68 | 33.56 ± 3.68 | 83.96 ± 2.42 | 16.04 ± 2.35 |
MDA-MB 231 | 77.14 ± 2.98 | 22.85 ± 2.98 | 82.66 ± 2.33 | 17.34 ± 2.33 |
T47D | 77.87 ± 2.60 | 22.12 ± 2.60 | 85.37 ± 1.93 | 14.62 ± 1.93 |